V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270015985 | 270008280 | 1.76 | 115 | Palliative (P) | 2016-12-10 | 2017-01-26 | CETUXIMAB | N | N | 270012347 | CETUXIMAB |
| 270015986 | 270008282 | 1.69 | 92 | Curative (C) | null | 2015-05-08 | Cetuximab 14 day | N | Y | 270012357 | CETUXIMAB |
| 270015987 | 270008284 | 1.76 | null | Curative (C) | null | 2017-07-19 | COPP + Dacarbazine | N | N | 270012363 | COPP + DACARBAZINE |
| 270015988 | 270008286 | 1.8 | 47.2 | Curative (C) | 2012-07-06 | 2013-04-03 | Cetuximab 7 day (>Cycle 2) | 02 | null | 270012368 | CETUXIMAB |
| 270015989 | 270008287 | 1.62 | 66.2 | Not known (9) | 2016-11-26 | 2016-11-26 | Trial Unspecified | N | N | 270012371 | TRIAL |
| 270015990 | 270008288 | null | 61.2 | Curative (C) | 2017-12-25 | 2018-02-23 | COPP + Dacarbazine | null | N | 270012379 | COPP + DACARBAZINE |
| 270015991 | 270008289 | null | null | Curative (C) | 2016-09-13 | 2016-11-24 | Escalated BEACOPP | 02 | N | 270012379 | BEACOPP |
| 270015992 | 270008291 | 0 | 56.9 | Curative (C) | 2014-08-03 | 2014-08-17 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270012381 | TRIAL |
| 270015993 | 270008293 | 1.43 | 53.8 | Curative (C) | 2017-12-27 | 2018-02-21 | COPP + Dacarbazine | N | N | 270012391 | COPP + DACARBAZINE |
| 270015994 | 270008298 | 0 | 85 | Curative (C) | 2016-02-18 | 2016-04-22 | COPP + Dacarbazine | 02 | N | 270012416 | COPP + DACARBAZINE |
| 270015995 | 270008300 | 1.78 | 78.8 | Curative (C) | 2017-06-08 | 2017-08-19 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012423 | TRIAL |
| 270015996 | 270013939 | null | null | Palliative (P) | 2015-03-02 | 2015-03-18 | Cetuximab 14 day | N | N | 270012431 | CETUXIMAB |
| 270015997 | 270008304 | 1.82 | 73.9 | Curative (C) | 2016-09-11 | 2016-11-21 | Trial Unspecified | 01 | N | 270012434 | TRIAL |
| 270015998 | 270013940 | 1.69 | 85 | Curative (C) | 2019-01-07 | 2019-04-13 | Trial Unspecified | null | N | 270012438 | TRIAL |
| 270015999 | 270008308 | 0 | 63 | null | null | 2015-08-30 | COPP + Dacarbazine | N | N | 270012440 | COPP + DACARBAZINE |
| 270016000 | 270008312 | 0 | 66.4 | Curative (C) | 2014-10-21 | 2015-01-14 | Trial Unspecified | Y | N | 270012461 | TRIAL |
| 270016001 | 270008316 | null | 84 | Curative (C) | null | 2016-08-04 | COPP + Dacarbazine | N | N | 270012463 | COPP + DACARBAZINE |
| 270016002 | 270008321 | 0 | null | Curative (C) | 2016-02-10 | 2016-06-21 | Trial Unspecified | N | null | 270012463 | TRIAL |
| 270016003 | 270008324 | null | null | Curative (C) | 2016-01-20 | 2016-01-27 | BEACOPP-14 | 02 | N | 270012474 | BEACOPP |
| 270016004 | 270008326 | 1.54 | null | Curative (C) | 2013-04-13 | 2013-07-26 | BEACOPP-14 | 01 | N | 270012475 | BEACOPP |
| 270016005 | 270008327 | 1.8 | 70 | Curative (C) | 2013-03-20 | 2013-07-11 | BEACOPP-14 | N | N | 270012476 | BEACOPP |
| 270016006 | 270008328 | 1.86 | 79.9 | null | 2014-08-05 | 2014-08-05 | BEACOPP-14 | 2 | N | 270012479 | BEACOPP |
| 270016007 | 270008331 | 1.65 | null | Curative (C) | 2015-07-15 | 2015-07-15 | COPP + Dacarbazine | N | N | 270012501 | COPP + DACARBAZINE |
| 270016008 | 270008335 | 0 | 57.6 | Curative (C) | 2016-02-04 | 2016-02-29 | COPP + Dacarbazine | N | N | 270012502 | COPP + DACARBAZINE |
| 270016009 | 270008336 | 1.87 | 71 | Curative (C) | 2017-01-19 | 2017-03-30 | Escalated BEACOPP | Y | N | 270012503 | BEACOPP |
| 270016010 | 270008338 | null | 46.5 | Curative (C) | 2016-05-04 | 2016-11-07 | Cetuximab 7 day (>Cycle 2) | 02 | N | 270012509 | CETUXIMAB |
| 270016011 | 270008342 | null | 41.1 | Curative (C) | 2013-09-06 | 2014-02-01 | CETUXIMAB | null | N | 270012525 | CETUXIMAB |
| 270016012 | 270008346 | 0 | 74.3 | null | 2017-08-16 | 2017-08-18 | COPP + Dacarbazine | N | null | 270012526 | COPP + DACARBAZINE |
| 270016013 | 270008349 | 0 | 77.4 | Palliative (P) | 2014-05-29 | 2014-08-06 | Trial Unspecified | 01 | N | 270012534 | TRIAL |
| 270016014 | 270008350 | 0 | 62.9 | Palliative (P) | 2015-12-06 | 2016-05-18 | CETUXIMAB | N | Y | 270012536 | CETUXIMAB |
| 270016015 | 270008351 | 1.81 | 76.2 | Palliative (P) | 2016-08-08 | 2016-09-20 | Cetuximab 14 day | null | N | 270012539 | CETUXIMAB |
| 270016016 | 270008352 | 0 | 86.8 | Curative (C) | 2016-05-13 | 2016-07-08 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012539 | TRIAL |
| 270016017 | 270008353 | 1.88 | 58.4 | Adjuvant (A) | 2016-11-30 | 2017-01-29 | COPP + Dacarbazine | 02 | N | 270012545 | COPP + DACARBAZINE |
| 270016018 | 270008355 | 0 | 49.1 | Neo-adjuvant (N) | 2015-08-01 | 2015-08-01 | COPP + Dacarbazine | 02 | null | 270012548 | COPP + DACARBAZINE |
| 270016019 | 270008359 | 0 | 47.8 | Curative (C) | 2014-07-30 | 2014-09-09 | COPP + Dacarbazine | N | N | 270012559 | COPP + DACARBAZINE |
| 270016020 | 270008360 | null | 57.6 | Curative (C) | 2017-03-06 | 2017-03-06 | COPP + Dacarbazine | N | N | 270012569 | COPP + DACARBAZINE |
| 270016021 | 270016642 | 0 | 61.2 | Curative (C) | null | 2014-01-29 | COPP + Dacarbazine | N | N | 270012579 | COPP + DACARBAZINE |
| 270016022 | 270016644 | 0 | 49.65 | Curative (C) | 2014-08-06 | 2014-08-06 | COPP + Dacarbazine | null | null | 270012583 | COPP + DACARBAZINE |
| 270016023 | 270016644 | 1.81 | 85.3 | Curative (C) | 2013-10-03 | 2014-07-04 | Cetuximab 14 day | 99 | N | 270012583 | CETUXIMAB |
| 270016024 | 270020137 | 1.63 | 96.1 | Curative (C) | 2017-07-17 | 2017-09-09 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012592 | TRIAL |
| 270016025 | 270008373 | 0 | 76.5 | null | 2013-11-03 | 2013-11-04 | COPP + Dacarbazine | 02 | N | 270012597 | COPP + DACARBAZINE |
| 270016026 | 270008376 | 1.91 | null | null | 2015-05-02 | 2015-08-18 | COPP + Dacarbazine | N | N | 270012598 | COPP + DACARBAZINE |
| 270016027 | 270008376 | 1.73 | 96 | Curative (C) | 2017-08-29 | 2017-10-03 | HD EuroNet-PHL-C1 COPDAC | null | N | 270012598 | TRIAL |
| 270016028 | 270008378 | 0 | 67.2 | Palliative (P) | 2013-09-12 | 2013-09-12 | COPP + Dacarbazine | N | N | 270012608 | COPP + DACARBAZINE |
| 270016029 | 270008378 | 1.55 | null | Neo-adjuvant (N) | 2017-02-11 | 2017-03-08 | COPP + Dacarbazine | N | N | 270012608 | COPP + DACARBAZINE |
| 270016030 | 270008382 | 1.74 | 78.4 | Curative (C) | 2017-03-05 | 2017-03-06 | Cetuximab 7 day (>Cycle 2) | 99 | N | 270012626 | CETUXIMAB |
| 270016031 | 270008382 | 0 | 55.6 | Curative (C) | 2014-10-28 | 2015-01-03 | COPP + Dacarbazine | N | N | 270012626 | COPP + DACARBAZINE |
| 270016032 | 270013971 | 1.75 | 62.7 | Curative (C) | 2014-11-24 | 2014-12-10 | BEACOPP-14 | N | N | 270012636 | BEACOPP |
| 270016033 | 270008386 | null | 79.7 | Curative (C) | 2014-12-04 | 2014-12-11 | HD EuroNet-PHL-C1 COPDAC | N | N | 270012646 | TRIAL |
| 270016034 | 270008387 | 0 | null | Curative (C) | 2019-05-24 | 2019-05-24 | COPP + Dacarbazine | N | N | 270012653 | COPP + DACARBAZINE |